Ypsilanti, MI, United States of America

Nian Zhuang

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nian Zhuang. Retrieved from https://idiyas.com/inventor/nian-zhuang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nian Zhuang: Innovator in Alzheimer's Disease Research

Introduction

Nian Zhuang is a notable inventor based in Ypsilanti, MI (US). He has made significant contributions to the field of Alzheimer's disease research. His innovative work focuses on methods to inhibit amyloid protein aggregation, which is crucial in the development of effective treatments for this debilitating condition.

Latest Patents

Nian Zhuang holds a patent for a method of inhibiting amyloid protein aggregation and imaging amyloid deposits. The patent describes a method of treating Alzheimer's disease using a compound of Formula (I). Additionally, it provides a method for inhibiting the aggregation of amyloid proteins and a method for imaging amyloid deposits, along with new compounds of Formula (I). He has 1 patent to his name.

Career Highlights

Zhuang is currently employed at Pfizer Corporation, a leading pharmaceutical company known for its commitment to innovative healthcare solutions. His work at Pfizer has allowed him to contribute to groundbreaking research in the treatment of Alzheimer's disease.

Collaborations

Throughout his career, Nian Zhuang has collaborated with esteemed colleagues, including Corinne E Augelli-Szafran and Mark Robert Barvian. These collaborations have further enhanced the impact of his research in the scientific community.

Conclusion

Nian Zhuang's contributions to Alzheimer's disease research through his innovative patent and work at Pfizer Corporation highlight his dedication to improving healthcare outcomes. His efforts in developing methods to combat amyloid protein aggregation are paving the way for future advancements in the treatment of this challenging disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…